PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; and genomics laboratory tests that provides genetic testing for reproductive health, pregnant women, couples who want to have a child, oncology tests, drug sensitivity, DNAandMe, and others. It also offers homecare health services for hemoglobin, ferritin, retilulosit, hematologi rutin, SARS-COV-2 omicron screening molecular test, and PCR SARS-COV-2 H+1 B2C; and SARS-CoV-2 screening services. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.
Metrics to compare | DGNS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDGNSPeersSector | |
---|---|---|---|---|
P/E Ratio | −69.9x | 9.4x | −0.6x | |
PEG Ratio | −1.50 | −0.01 | 0.00 | |
Price/Book | 0.9x | 2.1x | 2.6x | |
Price / LTM Sales | 1.1x | 2.1x | 3.4x | |
Upside (Analyst Target) | - | 25.4% | 35.5% | |
Fair Value Upside | Unlock | 9.2% | 3.7% | Unlock |